Abstract
Baseline CD4 testing rates declined from 73% to 21% between 2013 and 2018 with adoption of "Treat All"in Uganda. Advanced human immunodeficiency virus (HIV) disease (CD4 count < 200 cells/μL) remained common (24% of those tested in 2018, 83% of whom had World Health Organization stage I/II disease). Despite frequent presentation with advanced HIV disease, CD4 testing has declined dramatically.
Author supplied keywords
Cite
CITATION STYLE
Nasuuna, E., Tenforde, M. W., Muganzi, A., Jarvis, J. N., Manabe, Y. C., & Kigozi, J. (2020). Reduction in Baseline CD4 Count Testing following Human Immunodeficiency Virus “treat All” Adoption in Uganda. Clinical Infectious Diseases, 71(9), 2497–2499. https://doi.org/10.1093/cid/ciaa261
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
